Flabs
Maglumi 800: Automated Immunoassay Analyser Review
Traditional immunoassay analysers often face limitations in diagnostic labs: in throughput, reagent stability or user-friendliness, creating bottlenecks in workflows. These challenges can compromise turnaround times and impact patient care. Given that pathology laboratories and healthcare facilities are under pressure, an automated machine is imperative. That is where Malgumi 800 enters.
The Maglumi 800 addresses these issues by combining advanced ABEI chemiluminescence labelling technology with magnetic microbead separation. It provides a balance of high performance, streamlined operation, and scalability for small to medium-sized labs.
Technology Behind Maglumi 800
The Maglumi 800 is a chemiluminescence immunoassay (CLIA) system designed with two proprietary technologies.
ABEI Labelling Technology
Unlike enzyme-labelled reagents, which degrade under varying storage conditions, Maglumi 800 uses ABEI– a non-enzyme small molecule. It ensures high stability in both acidic and alkaline environments. Reactions between ABEI, sodium hydroxide, and hydrogen peroxide are complete in under 3 seconds, delivering consistent and rapid signal generation.
Magnetic Microbead Separation
Magnetic beads increase the reaction surface between antigens and antibodies, accelerating binding, improving sensitivity, and reducing intra- and inter-assay variation. It leads to more reliable results across a wide parameter list.
These innovations underpin the analyser’s precision and throughput capacity, differentiating it from conventional CLIA systems.
Maglumi 800 Technical Specifications
| Feature | Specification |
|---|---|
| Technology | CLIA (ABEI labelling + magnetic microbead separation) |
| Throughput | Up to 180 tests/hour |
| Sample Capacity | 40 tubes onboard, continuous loading |
| Reagent Capacity | 9 onboard with RFID, refrigerated |
| Time to First Result | 17 minutes |
| Modes of Operation | Random, Batch, STAT |
| Dimensions | 102 × 72 × 56 cm |
| Weight | 73 kg |
| Connectivity | Bidirectional LIS via TCP/IP and COM |
| Maintenance | Guided daily, weekly, and monthly schedules |
Maglumi 800 Test Menu
- Thyroid & Fertility markers (TSH, FT4, β-HCG, AMH)
- Cardiac markers (Troponin I, CK-MB, NT-proBNP)
- Tumour markers (CEA, AFP, PSA, CA-125)
- Infectious diseases (HBsAg, HIV Ab/Ag, SARS-CoV-2 assays)
- Bone metabolism & vitamin assays (25-OH Vitamin D, Osteocalcin)
- Autoimmune screening (ANA, Anti-CCP, Anti-dsDNA)
- Drug monitoring (Cyclosporine A, Tacrolimus, Digoxin)
Maglumi 800 Reagents and Parameter List
The analyser supports over 150 parameters across endocrinology, cardiology, oncology, infectious diseases, autoimmune disorders, and metabolism. Maglumi 800 reagents are ready-to-use, include calibrators, and are traceable via RFID tags. Reagent stability (up to 4 weeks calibration validity) reduces wastage and lowers operational costs.
The Maglumi 800 parameter list continues to expand, enabling labs to keep pace with evolving diagnostic needs without additional equipment investment.
Software and User Experience
The Maglumi 800 software is designed for intuitive operation.
- Real-time monitoring of tests, reagents, and consumables.
- Intelligent alarms and reagent tracking.
- QC integration with Westgard rules and Levey-Jennings charts.
- Multilingual interface supporting up to 10 languages.
- Comprehensive test summary with rerun tracking.
Maglumi 800 Uses in Clinical Settings
- Small to mid-sized laboratories and hospitals that need compact, reliable automation.
- Emergency testing with STAT priority mode.
- Broad diagnostic coverage across endocrine, oncology, and infectious disease panels.
- Routine monitoring in chronic conditions such as diabetes, renal disease, or cardiac disorders.
Maglumi 800 Price and Availability
The Maglumi 800 price varies depending on configuration, reagent contracts, and regional distribution. For laboratories in Asia, especially India, cost considerations include bundled reagent packages and service agreements. While the Maglumi 800 price in India is not universally fixed, laboratories should consult authorised distributors for quotations that factor in installation, LIS integration, and reagent supply.
When evaluating cost, it is important to compare the analyser’s total cost of ownership—including consumables, reagent stability, and calibration requirements—against competitors.
Conclusion
The Maglumi 800 represents a robust solution for laboratories seeking reliable CLIA performance in a compact system. With its advanced ABEI labelling, magnetic microbead separation, and wide-ranging test menu, it addresses diagnostic needs across endocrinology, oncology, cardiology, infectious disease, and autoimmune testing.
For pathologists and healthcare professionals, the system is an efficient balance of throughput, reagent stability, and usability. Ultimately, consideration of the Maglumi 800 price, reagent agreements, and laboratory test volumes will determine return on investment. Overall, Maglumi 800 is a strong contender for laboratories requiring future-ready expansion in diagnostics.
Suggested read - What Makes Maglumi X3 Ideal for Immunoassays
Get Started at ₹1!
Try Flabs for a full month for just ₹1.



